Search Results 1021-1030 of 15558 for Linaclotide

  1. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  2. IL-2 plus FOLFOX and Nivolumab for Treatment of Peritoneal Metastases - Mayo Clinic

    The purpose of this study is to evaluate the reduction in the peritoneal carcinomatosis index (PCI) after completion of the study treatment. Participation ...

  3. Breast cancer - Doctors and departments - Mayo Clinic

    Analyzing the genetic makeup of breast cancer cells to understand how DNA changes affect response to cancer treatments and personalize treatment options.

  4. A Study to Evaluate Minimal Residual Disease in Chronic Lymphocytic Leukemia - Mayo Clinic

    The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different anticoagulants. Participation ...

  5. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  6. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  7. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  8. Spinal stenosis - Doctors and departments - Mayo Clinic

    This condition narrows the amount of space within the spine. This can squeeze the nerves that travel through the spine. Surgery is sometimes needed.

  9. Neurology - Clinical trials

    Rochester, Minn. This is a study to generate feasibilty data regarding the collection of health and psychosocial outcomes after acquired spinal cord injury (SCI) ...

  10. A Study to Evaluate the Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer - Mayo Clinic

    Pembrolizumab has been approved for treatment of patients with melanoma but has not been proven to be safe or helpful in patients with pancreatic cancer and is ...